Plateau Iris
27 Plateau Iris Joel S. Schuman, MD, FACS; Malik Y. Kahook, MD; Rachel L. Anderson, MD; and David L. Epstein, MD, MMM PLATEAU IRIS CONFIGURATION AND PLATEAU IRIS SYNDROME Clinical…
Combined Open-Angle and Angle-Closure Glaucoma
39 Combined Open-Angle and Angle-Closure Glaucoma David L. Epstein, MD, MMM; Ari D. Schuman, MD, MS; and Joel S. Schuman, MD, FACS The obstruction to aqueous outflow in primary open-angle…
Angle-Closure Glaucoma Secondary to Occlusion of the Central Retinal Vein
36 Angle-Closure Glaucoma Secondary to Occlusion of the Central Retinal Vein Malik Y. Kahook, MD and David L. Epstein, MD, MMM Occlusion of the central retinal vein is not ordinarily…
Management of Highly Elevated Intraocular Pressure
18 Management of Highly Elevated Intraocular Pressure Joshua D. Stein, MD, MS; R. Rand Allingham, MD; and Pratap Challa, MD, MS The patient with acutely elevated intraocular pressure (IOP) is…
Carbonic Anhydrase Inhibitors: Systemic Use
14 Carbonic Anhydrase Inhibitors Systemic Use Pratap Challa, MD, MS and David L. Epstein, MD, MMM Carbonic anhydrase inhibitors (CAIs) can be useful in the treatment of all the glaucomas…
Principles of Secondary Angle-Closure Glaucomas
29 Principles of Secondary Angle-Closure Glaucomas David L. Epstein, MD, MMM In Chapter 23, the mechanisms underlying the primary angle-closure glaucomas were discussed. The fundamental concept was that of pupillary…
The Use of Special Tests in Narrow-Angled Eyes
28 The Use of Special Tests in Narrow-Angled Eyes Joel S. Schuman, MD, FACS; Rachel L. Anderson, MD; and David L. Epstein, MD, MMM Surgical iridectomy carried significant risk, and…
Subacute (and Chronic) Angle-Closure Glaucoma
25 Subacute (and Chronic) Angle-Closure Glaucoma Jeffrey R. SooHoo, MD; David L. Epstein, MD, MMM; and George Ulrich, MD, FACS The principles underlying the pathogenesis, diagnosis, and treatment of subacute…
Adrenergic Agents: Blockers and Agonists
12 Adrenergic Agents Blockers and Agonists Pratap Challa, MD, MS and David L. Epstein, MD, MMM Topical beta-blockers decrease aqueous humor formation (AHF)1,2 and are used long term in the…
